Obstructive Sleep Apnea Syndrome: Prediction of Lipid Panel in Relation to Apnea- Hypopnea Index.

Indian J Otolaryngol Head Neck Surg

Otorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, 13511 Qalyubia Egypt.

Published: January 2025

The research was designed to predict the relationship between the apnea-hypopnea index (AHI) as the main indicator of severity of obstructive sleep apnea syndrome (OSAS), and lipid panel test results. A cross-sectional observational study was done on 90 patients with suspected sleep-related breathing disorders as assumed by polysomnography. Patients were categorized into three equal groups depending on AHI: mild degree (5-15 events/hour), moderate degree (15-30 events/hour), and severe degree (> 30 events/hour). All patients underwent a comprehensive medical history, PSG, and lipid panel tests, which included measurements of total cholesterol level, low-density lipoprotein (LDL) level, very low-density lipoprotein (VLDL) level, high-density lipoprotein (HDL) level, and triglycerides (TGs) level. Aclose relation was noted between degree of severity of OSA and lipid panel tests that in third group (Severe degree) exhibited significantly higher levels of triglycerides (212 ± 36 mg/dL), total cholesterol (180 ± 54 mg/dL), and LDL (178.1 ± 39.8 mg/dL) compared to those with moderate (TGs: 158 ± 57 mg/dL, total cholesterol: 151 ± 65 mg/dL, LDL: 153.2 ± 31.5 mg/dL) and mild OSA (TGs: 106 ± 37 mg/dL, total cholesterol: 85 ± 12 mg/dL, LDL: 87 ± 9.3 mg/dL), with P-values < 0.001. Conversely, significantly lower level of HDLin the severe OSA group (25.8 ± 3.6 mg/dL) compared to moderate (32.7 ± 4.2 mg/dL) and mild OSA groups (45.8 ± 9.2 mg/dL), with a -value < 0.001. so analysis of Multivariate linear regression unveiled that both moderate and severe OSA stood as independent predictors for elevated TC, TGs, and LDL levels, alongside diminished HDL levels, according to age, sex, and BMI. Oxygen desaturation due to OSA significantly impacts lipid metabolism, leading to dyslipidemia and increased cardiovascular risk.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890882PMC
http://dx.doi.org/10.1007/s12070-024-05178-6DOI Listing

Publication Analysis

Top Keywords

lipid panel
16
total cholesterol
16
obstructive sleep
8
sleep apnea
8
apnea syndrome
8
severe degree
8
panel tests
8
level low-density
8
low-density lipoprotein
8
degree
5

Similar Publications

Obstructive Sleep Apnea Syndrome: Prediction of Lipid Panel in Relation to Apnea- Hypopnea Index.

Indian J Otolaryngol Head Neck Surg

January 2025

Otorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, 13511 Qalyubia Egypt.

The research was designed to predict the relationship between the apnea-hypopnea index (AHI) as the main indicator of severity of obstructive sleep apnea syndrome (OSAS), and lipid panel test results. A cross-sectional observational study was done on 90 patients with suspected sleep-related breathing disorders as assumed by polysomnography. Patients were categorized into three equal groups depending on AHI: mild degree (5-15 events/hour), moderate degree (15-30 events/hour), and severe degree (> 30 events/hour).

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are secreted by most cell types and play a central role in cell-cell communication. These naturally occurring nanoparticles have been particularly implicated in cancer, but EV heterogeneity and lengthy isolation methods with low yield make them difficult to study. To circumvent the challenges in EV research, we aimed to develop a unique synthetic model by engineering bioinspired liposomes to study EV properties and their impact on cellular uptake.

View Article and Find Full Text PDF

PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.

Metabolomics

March 2025

Department of Digestive and Hepatobiliary Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France.

Introduction: Metabolic steatotic liver disease (MASLD) can progress to hepatocellular carcinoma (HCC). 25% of MASLD-HCCs occur in the absence of fibrosis.

Objectives: This study aimed to explore lipid metabolic pathways through "omics" and to identify biomarkers of MASLD-HCC based on the degree of fibrosis.

View Article and Find Full Text PDF

Objectives: Hepatotoxicity is a frequent reason why disease-modifying anti-rheumatic drugs (DMARDs) are stopped or changed. We hypothesize that features of metabolic syndrome (such as obesity, dyslipidemia, and diabetes) are risk factors for hepatotoxicity leading to DMARD change in rheumatoid arthritis (RA).

Methods:  We conducted a retrospective chart review of 361 patients with RA.

View Article and Find Full Text PDF

Objective: The concurrent presence of multiple chronic diseases, termed multimorbidity, is increasingly prevalent among patients with chronic illnesses. This phenomenon is particularly pronounced in middle-aged women, yet has not received adequate attention. The objective of this study was to investigate the pattern of multimorbidity and its changes over time in perimenopausal women.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!